Form 4: CME Officer Vroman's Equity Changes Post-Vesting

CME Group's Chief Transformation Officer, Ken Vroman, reported the vesting of performance shares and subsequent sale for tax obligations.

Summary

• Ken Vroman, Chief Transformation Officer of CME Group Inc. (CME), reported changes in his beneficial ownership of Common Stock Class A.
• On March 15, 2026, Vroman acquired 7,076 shares of Common Stock Class A at a price of $311.4 per share.
• This acquisition represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan.
• The number of vested shares was determined by the company's total shareholder return relative to the S&P 500 over a three-year performance period from January 1, 2023, through December 31, 2025.
• Concurrently, Vroman disposed of 3,135 shares of Common Stock Class A at $311.4 per share to fulfill tax withholding obligations related to the performance share award.
• Following these transactions, Vroman beneficially owns 18,851 shares of Common Stock Class A.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. It is a routine insider transaction related to executive compensation, indicating performance targets were met but not providing new fundamental insights into the company's operational or financial health.

Positives

• The vesting of 7,076 performance shares indicates that CME Group met its total shareholder return targets relative to the S&P 500 over the specified performance period (January 1, 2023, to December 31, 2025).

Negatives

• A disposition of 3,135 shares occurred to cover tax withholding obligations, which is a reduction in direct beneficial ownership.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• The vesting of performance shares reflects the company's achievement of total shareholder return relative to the S&P 500 over the specified performance period.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures of insider transactions, reflecting executive compensation structures common in the financial industry. The vesting of performance shares tied to relative total shareholder return is a standard practice designed to align executive incentives with shareholder interests.

Comparison to Industry Standards

• The use of performance shares tied to relative total shareholder return (TSR) against a benchmark like the S&P 500 is a common and widely accepted executive compensation practice across the financial services industry, including major exchanges and financial technology companies such as Intercontinental Exchange (ICE) or Nasdaq (NDAQ).
• The disposition of shares to cover tax withholding obligations upon vesting is also a standard procedure for equity-based compensation, consistent with practices observed at peer companies.

Stakeholder Impact

• Shareholders: The vesting of performance shares suggests that the company's performance metrics, specifically total shareholder return relative to the S&P 500, were achieved, which is generally positive for shareholders. The disposition for tax purposes is a routine event and does not significantly impact the broader shareholder base.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving the vesting of performance shares and a subsequent sale to cover tax obligations. Such transactions are common for executive compensation and typically do not indicate a change in the company's fundamental outlook or warrant a significant shift in investment strategy. Therefore, a 'hold' recommendation is appropriate as this filing provides no new information to alter an existing investment thesis.

Keywords

CME Group, CME, Form 4, Insider Transaction, Stock Vesting, Performance Shares, Executive Compensation, Beneficial Ownership